COMP <GO>
AROC vs XOM // EV/EBITDA & P/E VALUATION
Archrock Inc. (NYSE) VS. Exxon Mobil Corporation (NYSE) • 15-METRIC TALLY: AROC 7
— XOM 7
▲ EV/EBITDA & P/E VALUATION LEADER: XOM
LAST: $31.70 (-1.25%) • MKT CAP: $5.63B
valuation
17.9x
LAST: $187.25 (+2.16%) • MKT CAP: $748.46B
valuation
13.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AROC VS. XOM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AROC | XOM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.00% | 9.86% | -1.86 | XOM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.9x | 13.9x | +4.03 | XOM | /valuation <GO> |
| Free Cash Flow Yield | 9.86% | 2.51% | +7.35 | AROC | /fcf-yield <GO> |
| Operating Margin | 26.40% | 10.96% | +15.44 | AROC | /operating-margins <GO> |
| Net Profit Margin | 21.60% | 7.57% | +14.03 | AROC | /net-margins <GO> |
| Revenue Growth (YoY) | 28.70% | -4.40% | +33.10 | AROC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.52% | 2.20% | +0.32 | AROC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.13 | 4.65 | -3.52 | XOM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | AROC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.22% | +0.28 | XOM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.8 | 73.0 | -15.17 | XOM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.28 | +0.61 | AROC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.7x | 14.3x | +0.36 | XOM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.63B | $748.46B | -$742.83B | XOM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AROC REV | XOM REV | AROC GROSS % | XOM GROSS % | AROC FCF | XOM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.49B | $332.24B | 48.6% | — | $555.1M | $23.61B |
| FY 2024 | $1.16B | $349.58B | 43.7% | — | $377.5M | $30.72B |
| FY 2023 | $990.3M | $344.58B | 44.0% | — | $265.6M | $33.45B |
| FY 2022 | — | $413.68B | — | — | — | $58.39B |
| FY 2021 | — | $285.64B | — | — | — | $36.05B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AROC // BETA 0.89
XOM // BETA 0.28